Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
Walter Ling,1 Steve Shoptaw,1 David Goodman-Meza2 1UCLA Department of Family Medicine, Center for Behavioral and Addiction Medicine, Los Angeles, CA, USA; 2UCLA Department of Medicine, Division of Infectious Diseases, Los Angeles, CA, USACorrespondence: Walter Ling Email lwalter@ucla.eduAbstract: Bu...
Saved in:
Main Authors: | Ling W (Author), Shoptaw S (Author), Goodman-Meza D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum]
by: Ling W, et al.
Published: (2020) -
Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study
by: Björn Johnson, et al.
Published: (2022) -
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
by: R. Ling, et al.
Published: (2022) -
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024) -
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023)